![](/images/graphics-bg.png)
Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
Joint Authors
Ghazanfar, Misbah Nasheela
Thomsen, Simon Francis
Source
Case Reports in Dermatological Medicine
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-09-08
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Urticarial vasculitis is characterised by inflamed itching or burning red patches or wheals that resemble urticaria but persist for greater than 24 hours.
It is often idiopathic but is sometimes associated with collagen-vascular disease, particularly systemic lupus erythematosus.
Treatment options include oral antihistamines, oral corticosteroids, dapsone, colchicine or hydroxychloroquine.
We describe a male patient with urticarial vasculitis who was treated with omalizumab (anti-IgE) with convincing results and provide a review of previous reports of patients with urticarial vasculitis treated with omalizumab.
American Psychological Association (APA)
Ghazanfar, Misbah Nasheela& Thomsen, Simon Francis. 2015. Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature. Case Reports in Dermatological Medicine،Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058371
Modern Language Association (MLA)
Ghazanfar, Misbah Nasheela& Thomsen, Simon Francis. Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature. Case Reports in Dermatological Medicine No. 2015 (2015), pp.1-3.
https://search.emarefa.net/detail/BIM-1058371
American Medical Association (AMA)
Ghazanfar, Misbah Nasheela& Thomsen, Simon Francis. Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature. Case Reports in Dermatological Medicine. 2015. Vol. 2015, no. 2015, pp.1-3.
https://search.emarefa.net/detail/BIM-1058371
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058371